Daré Bioscience, Inc. (DARE)
1.85
+0.08
(+4.52%)
USD |
NASDAQ |
Apr 08, 16:00
1.80
-0.05
(-2.70%)
After-Hours: 20:00
Daré Bioscience EPS Diluted (Quarterly) : -0.0994 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.442M |
| Revenue (Quarterly) | 1.024M |
| Total Expenses (Quarterly) | 2.465M |
| Enterprise Value | 10.28M |
| Gross Profit Margin (Quarterly) | 5.74% |
| Profit Margin (Quarterly) | -140.8% |
| Earnings Yield | -68.86% |
| Normalized Earnings Yield | -68.86 |